Related Experiment Video
Updated: Dec 25, 2025
10:43
Author Spotlight: Single-Molecule Surface-Enhanced Raman Scattering Measurements Enabled by Plasmonic DNA Origami Nanoantennas
Published on: July 21, 2023
3.9K
Sensitive and Direct DNA Mutation Detection by Surface-Enhanced Raman Spectroscopy Using Rational Designed and
Analytical Chemistry
|April 1, 2020
Summary
This study introduces a sensitive method using plasmonic nanostructures and SERS to detect BRAF V600E mutations in DNA. The technique accurately distinguishes between wild-type and mutant genes for potential clinical applications.
Area of Science:
- Biotechnology
- Nanotechnology
- Molecular Biology
Background:
- Accurate DNA mutation detection is crucial for cancer diagnosis and personalized medicine.
- Current methods require improvement in sensitivity and specificity for clinical utility.
Purpose of the Study:
- To develop a straightforward and highly sensitive method for identifying and classifying BRAF wild type (WT) and V600E mutant genes.
- To combine plasmonic nanostructures, SERS, and PCR with statistical analysis for DNA mutation detection.
Main Methods:
- Synthesis and characterization of various gold/silver plasmonic nanostructures (nanospheres, nanoshells, nanoflowers, nanostars).
- Utilizing gold/silver nanostars for surface-enhanced Raman spectroscopy (SERS) based DNA mutation detection.
- Employing polymerase chain reaction (PCR) for specific DNA amplification and statistical analysis (PCA-LDA) for classification.
Main Results:
- Gold/silver nanostars exhibited the highest SERS activity, enabling detection of as few as 100 DNA copies.
- The combined SERS-PCR-statistical method successfully differentiated BRAF WT and V600E mutant genes from cell lines and cell-free DNA.
- The assay demonstrated specificity and accuracy in classifying mutations from a real plasma sample.
Conclusions:
- The direct SERS strategy with active plasmonic nanostructures offers a sensitive and specific alternative for DNA mutation detection.
- This approach holds potential for monitoring clinical nucleotide biomarkers, aiding in disease diagnosis and treatment evaluation.
